Open access · CC-BY
via OpenAlex
Plasma taurine level is linked to symptom burden and clinical outcomes in post-COVID condition
Mobin Khoramjoo, Kaiming Wang, Karthik Srinivasan, Mahmoud Gheblawi, Rupasri Mandal, Simon Rousseau, David Scott Wishart, Vinay Prasad, Lawrence P. Richer, Angela M. Cheung, Gavin Y. Oudit
PLoS ONE · 2024 · ▲ 13 citations
Abstract
BACKGROUND: A subset of individuals (10-20%) experience post-COVID condition (PCC) subsequent to initial SARS-CoV-2 infection, which lacks effective treatment. PCC carries a substantial global burden associated with negative economic and health impacts. This study aims to evaluate the association between plasma taurine levels with self-reported symptoms and adverse clinical outcomes in patients with PCC. METHODS AND FINDINGS: We analyzed the plasma proteome and metabolome of 117 individuals during their acute COVID-19 hospitalization and at the convalescence phase six-month post infection. Findings were compared with 28 age and sex-matched healthy controls. Plasma taurine levels were negatively associated with PCC symptoms and correlated with markers of inflammation, tryptophan metabolism, and gut dysbiosis. Stratifying patients based on the trajectories of plasma taurine levels during six-month follow-up revealed a significant association with adverse clinical events. Increase in taurine levels during the transition to convalescence were associated with a reduction in adverse events independent of comorbidities and acute COVID-19 severity. In a multivariate analysis, increased plasma taurine level between acute and convalescence phase was associated with marked protection from adverse clinical events with a hazard ratio of 0.13 (95% CI: 0.05-0.35; p<0.001). CONCLUSIONS: Taurine emerges as a promising predictive biomarker and potential therapeutic target in PCC. Taurine supplementation has already demonstrated clinical benefits in various diseases and warrants exploration in large-scale clinical trials for alleviating PCC.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1371/journal.pone.0304522
- Canonical
- link ↗
- Fetched
- 2026-11-15 MST
Cite this
APA
Khoramjoo, M., Wang, K., Srinivasan, K., Gheblawi, M., Mandal, R., Rousseau, S., Wishart, D.S., Prasad, V., Richer, L.P., Cheung, A.M., & Oudit, G.Y. (2024). Plasma taurine level is linked to symptom burden and clinical outcomes in post-COVID condition. <em>PLoS ONE</em>. https://doi.org/10.1371/journal.pone.0304522
Vancouver
Khoramjoo M, Wang K, Srinivasan K, Gheblawi M, Mandal R, Rousseau S, et al. Plasma taurine level is linked to symptom burden and clinical outcomes in post-COVID condition. PLoS ONE. 2024. doi:10.1371/journal.pone.0304522.
BibTeX
@article{mobin2024Plasma,
title = {Plasma taurine level is linked to symptom burden and clinical outcomes in post-COVID condition},
author = {Mobin Khoramjoo and Kaiming Wang and Karthik Srinivasan and Mahmoud Gheblawi and Rupasri Mandal and Simon Rousseau and David Scott Wishart and Vinay Prasad and Lawrence P. Richer and Angela M. Cheung and Gavin Y. Oudit},
journal = {PLoS ONE},
year = {2024},
doi = {10.1371/journal.pone.0304522},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Translational research 2020
Open access · OA
Gastrointestinal symptoms associated with COVID-19: impact on the gut microbiome
PLoS ONE 2012
Open access · CC-BY
Persistent Systemic Inflammation is Associated with Poor Clinical Outcomes in COPD: A Novel Phenotype
Journal of advanced research 2026
Open access · OA
Plasma proteomics identify novel biomarkers and dynamic patterns of biological aging.
Endocrinology and metabolism (Seoul, Korea) 2026
Citation only
Link between Circulating CCL2 Levels and Sarcopenia: Evidence from a Cohort Study, the UK Biobank, and Human GTEx Transcriptomic Data.
Vestre Viken Hospital Trust 2024
Open access · US-GOV
INTEgRated Health CARE for Patients With Frailty and Heart Failure (INTERCARE-HF): Evaluation of an Innovation Project
European Journal of Preventive Cardiology 2026
Open access · CC-BY